NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Victor Van De Wiele
University of Cambridge - Cambridge / United Kingdom
Law / Law and Legal Studies
AD Scientific Index ID: 5144027
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Victor Van De Wiele's MOST POPULAR ARTICLES
1-)
Assessment of variation in state regulation of generic drug and interchangeable biologic substitutionsCA Sacks, VL Van de Wiele, LA Fulchino, L Patel, AS Kesselheim, ...JAMA internal medicine 181 (1), 16-22, 2021302021
2-)
Barriers To US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation: Article examines barriers to US biosimilar market growth.VL Van de Wiele, AS Kesselheim, A SarpatwariHealth Affairs 40 (8), 1198-1205, 2021202021
3-)
The characteristics of patents impacting availability of biosimilarsVL Van de Wiele, RF Beall, AS Kesselheim, A SarpatwariNature Biotechnology 40 (1), 22-25, 2022162022
4-)
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseasesVL Van de Wiele, M Hammer, R Parikh, WB Feldman, A Sarpatwari, ...Journal of Law and the Biosciences 9 (1), lsac001, 202292022
5-)
Frequency of approval and marketing of biosimilars with a skinny label and associated Medicare savingsAC Egilman, VL Van de Wiele, BN Rome, JJ Darrow, SS Tu, ...JAMA Internal Medicine 183 (1), 82-84, 202362023
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept